Business

Merck Q4 net drops 14 pct. on generic competition

By Linda Johnson
Published February 5, 2014 4:25pm ET
Add Washington Examiner on Google
Merck Q4 net drops 14 pct. on generic competition
In this Thursday, Feb. 28, 2013 photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. Merck & Co. reports quarterly financial results before the market opens on Wednesday, Feb. 5, 2014. (AP Photo/Matt Rourke) | Matt Rourke

WHITEHOUSE STATION, N.J. (AP) — Merck & Co.’s fourth-quarter profit dropped 14 percent, with its aggressive cost cutting not enough to offset restructuring charges, generic competition to former blockbuster medicines and unfavorable currency exchange rates.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Pharmaceutical Industry